vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与合众银行（OSBC）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是IRONWOOD PHARMACEUTICALS INC的2.0倍（$93.8M vs $47.7M），合众银行净利率更高（27.3% vs -4.8%，领先32.1%），过去两年合众银行的营收复合增速更高（15.1% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
合众银行是一家总部位于美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押等金融服务。
IRWD vs OSBC — 直观对比
营收规模更大
OSBC
是对方的2.0倍
$47.7M
净利率更高
OSBC
高出32.1%
-4.8%
两年增速更快
OSBC
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $93.8M |
| 净利润 | $-2.3M | $25.6M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | — |
| 净利率 | -4.8% | 27.3% |
| 营收同比 | -47.3% | — |
| 净利润同比 | -200.9% | 159.2% |
| 每股收益（稀释后） | $0.01 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDOSBC
| Q1 26 | — | $93.8M | ||
| Q4 25 | $47.7M | $95.2M | ||
| Q3 25 | $122.1M | $95.9M | ||
| Q2 25 | $85.2M | $75.1M | ||
| Q1 25 | $41.1M | $73.1M | ||
| Q4 24 | $90.5M | $73.2M | ||
| Q3 24 | $91.6M | $71.2M | ||
| Q2 24 | $94.4M | $70.8M |
净利润IRWDOSBC
| Q1 26 | — | $25.6M | ||
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $9.9M | ||
| Q2 25 | $23.6M | $21.8M | ||
| Q1 25 | $-37.4M | $19.8M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | $23.0M | ||
| Q2 24 | $-860.0K | $21.9M |
营业利润率IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | 14.3% | 41.2% | ||
| Q3 25 | 61.8% | 13.6% | ||
| Q2 25 | 53.2% | 38.9% | ||
| Q1 25 | -70.7% | 35.8% | ||
| Q4 24 | 34.8% | 34.7% | ||
| Q3 24 | 28.0% | 41.9% | ||
| Q2 24 | 26.5% | 41.2% |
净利率IRWDOSBC
| Q1 26 | — | 27.3% | ||
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | 10.3% | ||
| Q2 25 | 27.7% | 29.0% | ||
| Q1 25 | -90.9% | 27.1% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | 32.3% | ||
| Q2 24 | -0.9% | 30.9% |
每股收益（稀释后）IRWDOSBC
| Q1 26 | — | $0.48 | ||
| Q4 25 | $0.01 | $0.53 | ||
| Q3 25 | $0.23 | $0.18 | ||
| Q2 25 | $0.14 | $0.48 | ||
| Q1 25 | $-0.23 | $0.43 | ||
| Q4 24 | $0.03 | $0.42 | ||
| Q3 24 | $0.02 | $0.50 | ||
| Q2 24 | $-0.01 | $0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $115.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-261.8M | $893.3M |
| 总资产 | $396.9M | $6.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRWDOSBC
| Q1 26 | — | $115.7M | ||
| Q4 25 | $215.5M | $124.0M | ||
| Q3 25 | $140.4M | $116.5M | ||
| Q2 25 | $92.9M | $141.8M | ||
| Q1 25 | $108.5M | $256.1M | ||
| Q4 24 | $88.6M | $99.3M | ||
| Q3 24 | $88.2M | $115.8M | ||
| Q2 24 | $105.5M | $120.9M |
总债务IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — |
股东权益IRWDOSBC
| Q1 26 | — | $893.3M | ||
| Q4 25 | $-261.8M | $896.8M | ||
| Q3 25 | $-264.2M | $866.7M | ||
| Q2 25 | $-308.2M | $718.6M | ||
| Q1 25 | $-334.1M | $694.5M | ||
| Q4 24 | $-301.3M | $671.0M | ||
| Q3 24 | $-311.3M | $661.4M | ||
| Q2 24 | $-321.7M | $619.3M |
总资产IRWDOSBC
| Q1 26 | — | $6.8B | ||
| Q4 25 | $396.9M | $6.9B | ||
| Q3 25 | $396.1M | $7.0B | ||
| Q2 25 | $342.9M | $5.7B | ||
| Q1 25 | $327.2M | $5.7B | ||
| Q4 24 | $350.9M | $5.6B | ||
| Q3 24 | $389.5M | $5.7B | ||
| Q2 24 | $395.6M | $5.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | — |
| 自由现金流经营现金流 - 资本支出 | $74.6M | — |
| 自由现金流率自由现金流/营收 | 156.3% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $127.0M | — |
8季度趋势，按日历期对齐
经营现金流IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $122.3M | ||
| Q3 25 | $47.6M | $35.9M | ||
| Q2 25 | $-15.1M | $24.2M | ||
| Q1 25 | $20.0M | $17.8M | ||
| Q4 24 | $15.2M | $131.5M | ||
| Q3 24 | $9.9M | $48.5M | ||
| Q2 24 | $33.5M | $11.6M |
自由现金流IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $117.8M | ||
| Q3 25 | $47.6M | $34.7M | ||
| Q2 25 | $-15.1M | $23.5M | ||
| Q1 25 | $19.9M | $16.2M | ||
| Q4 24 | — | $120.7M | ||
| Q3 24 | $9.9M | $46.2M | ||
| Q2 24 | $33.4M | $8.7M |
自由现金流率IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | 123.7% | ||
| Q3 25 | 39.0% | 36.2% | ||
| Q2 25 | -17.7% | 31.2% | ||
| Q1 25 | 48.4% | 22.2% | ||
| Q4 24 | — | 165.0% | ||
| Q3 24 | 10.8% | 64.9% | ||
| Q2 24 | 35.4% | 12.3% |
资本支出强度IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 4.7% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.1% | 2.2% | ||
| Q4 24 | 0.0% | 14.7% | ||
| Q3 24 | 0.0% | 3.3% | ||
| Q2 24 | 0.1% | 4.2% |
现金转化率IRWDOSBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 3.64× | ||
| Q2 25 | -0.64× | 1.11× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 2.11× | ||
| Q2 24 | — | 0.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
OSBC
| Net Interest Income | $81.1M | 87% |
| Noninterest Income | $12.6M | 13% |
